SHEKHAR GHAMANDE to Immunocompromised Host
This is a "connection" page, showing publications SHEKHAR GHAMANDE has written about Immunocompromised Host.
Connection Strength
0.308
-
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021. MMWR Morb Mortal Wkly Rep. 2021 Sep 24; 70(38):1337-1343.
Score: 0.164
-
Invasive diagnostic strategies in immunosuppressed patients with acute respiratory distress syndrome. Clin Chest Med. 2014 Dec; 35(4):697-712.
Score: 0.101
-
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 28; 71(4):118-124.
Score: 0.042